"urothelial carcinoma" trang 2 - tải miễn phí từ tailieuXANH
Epicure: A European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy

Epicure: A European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy
9    50    0
Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014

Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
11    60    0
A diagnostic marker for superficial urothelial bladder carcinoma: Lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression

A diagnostic marker for superficial urothelial bladder carcinoma: Lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression
11    69    0
Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study

Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study
9    45    0
Metabolic syndrome and the risk of urothelial carcinoma of the bladder: A case-control study

Metabolic syndrome and the risk of urothelial carcinoma of the bladder: A case-control study
7    59    0
Young age increases the risk of lymphnode metastasis in patients with muscleinvasive bladder urothelial carcinoma

Young age increases the risk of lymphnode metastasis in patients with muscleinvasive bladder urothelial carcinoma
6    59    0
5α-reductase inhibitors impact prognosis of urothelial carcinoma

5α-reductase inhibitors impact prognosis of urothelial carcinoma
7    53    0
High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
11    32    0
DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors
11    53    0
A panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysis

A panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysis
13    48    0
Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice

Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice
9    46    0
Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma

Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma
10    75    0
Canonical Notch signalling is inactive in urothelial carcinoma

Canonical Notch signalling is inactive in urothelial carcinoma
13    61    0
Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder

Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
8    161    0
HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma

HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma
11    56    0
Genomic profiling of Chinese patients with urothelial carcinoma

Genomic profiling of Chinese patients with urothelial carcinoma
11    62    1
Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area

Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area
9    48    1
Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines

Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines
13    13    1
Mass cytometry reveals immune atlas of urothelial carcinoma

Mass cytometry reveals immune atlas of urothelial carcinoma
13    205    1
Improving anticancer effects of aPD-L1 through lowering neutrophil infiltration by PLAG in tumor implanted with MB49 mouse urothelial carcinoma

Improving anticancer effects of aPD-L1 through lowering neutrophil infiltration by PLAG in tumor implanted with MB49 mouse urothelial carcinoma
11    20    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.